期刊文献+

急性冠状动脉综合征药物治疗现状

下载PDF
导出
摘要 急性冠状动脉综合征(ACS)是近20年来心血管疾病研究的热点,由于对ACS的病理基础和发病机制的研究有了引人注目的进展,进而导致了治疗策略的巨大变化。
出处 《中国循环杂志》 CSCD 北大核心 2004年第5期395-398,共4页 Chinese Circulation Journal
  • 相关文献

参考文献29

  • 1Clopidogrel in Unstable Angina to Prevent Recurrent Events Investigators.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J Med,2001,345:494-502.
  • 2Mehta SR,Yusuf S,Peters RJ,et al.for the CURE investigators.Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study.Lancet,2001,358:527-533.
  • 3The GUSTO Ⅳ-ACS Investigators.Effect of glycoprotein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: The GUSTO Ⅳ-ACS randomised trial.Lancet,2001,357:1915-1924.
  • 4Boersma E,Akkerhuis KM,Theroux P,et al.Platelet glycoprotein Ⅱb/Ⅲa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only,with additional protection during percutaneous coronary intervention.Circula
  • 5The CAPTURE investigators.Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study.Lancet,1997, 349:1429-1435.
  • 6The PURSUIT Trial Investigators.Inhibition of platelet glycoprotein Ⅱb/Ⅲa with eptifibatide in patients with acute coronary syndromes.N Engl J Med,1998,339:436-443.
  • 7Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators.Inhibition of the platelet glycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myoc
  • 8Boersma E,Harrington RA,Moliterno DJ,et al.Platelet glycoprotein Ⅱb/Ⅲa inhibitors in acute coronary syndromes: A meta-analysis of all major randomised clinical trials.Lancet,2002,359:189-198.
  • 9Goodman SG,Cohen M,Bigonzi F,et al.Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study.Efficacy and safety of Subcutaneous Enoxaparin in No
  • 10Antman EM,Cohen M,Radley D,et al.for the TIMI 11B and ESSENCE Investigators.Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction.TIMI 11B-ESSENCE meta-analysis.Circulation,1999, 100:1602-1608.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部